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trauma and disability. Intramedullary decompression of acute spinal cord contusion
in acute phase is one of the important therapeutic exploration methods. Due to the
lack of multicenter, randomized, double-blind, placebo-controlled clinical studies,
true effect of this treatment remains controversial.
Objective of the study: This design of the study is to explore the safety and neurorestorative effects of intramedullary decompression for acute complete spinal cord
contusion injury.
Design of the study: We design the prospective, multicenter, randomized, doubleblind placebo-controlled trial (MRDPT) for acute (less than 24 hours after injury)
spinal cord contusion injury. Sixty patients with acute complete spinal cord contusion
injury (20 in cervical 4 to thoracic 1, 20 in thoracic 2 to thoracic 9, and 20 in thoracic
10 to lumbar vertebra 1) are selected according to the selected conditions. All patients
receive conventional treatments such as reduction and fixation of spinal fractures
and/or spinal spondylolisthesis, bone external decompression relieves spinal cord
compression. At the same time, group A (n = 30, 10 of each segment group) undergoes
intramedullary decompression surgery and group B (n = 30) does not undergo
intramedullary decompression. All relevant functional changes before, after, and
during the follow-up period are recorded to ensure objective evaluation of the results
of the treatment.
Ethics and dissemination: The clinical study protocol and consent form were approved
by China Branch of International Association of Neurorestoratology and the ethics
committees of the hospitals which join this trial. Registration No. of this study is
ChiCTR1800020458. Findings will be published in peer-reviewed journals.

1

Background and introduction

Spinal cord injury (SCI) is one of the main causes of
severe neurological trauma and disability. Patients

with acute complete SCI can cause complete loss of
sensory, motor and sphincter function below the injured
segment, which seriously affects the patients’ quality
of life and imposes a huge burden on families and
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society [1, 2].
At present, neurorestorative therapy such as cell
therapy, nerve bridges, neuromodulation and braincomputer interface can improve the function for
patients with SCI to a certain extent, but the effective
degree of neurorestoration still needs to be improved
[3−8]. The professional circle has also been searching
for better neurorestorative methods. Procedure of
intramedullary decompression preventing the spinal
cord compartment syndrome has long history [9−16].
It may be one of the important potential therapeutic
methods for acute spinal cord contusion injury [15−23].
Due to the lack of multicenter, randomized, doubleblind, controlled clinical studies, so far this treatment
technology remains controversial whether it is truly
effective.
On May 26, 2018, the China Branch of International
Association of Neurorestoratology (IANR) discussed
and decided to organize a clinical trial which is
prospective multicenter, randomized, double-blind
intramedullary decompression for acute complete
spinal cord contusion injury. The aim of this study is
to explore the safety and neurorestorative effects of
intramedullary decompression for patients with acute
complete spinal cord contusion injury.

2

Research protocol

2.2

Study design

That is a prospective, multicenter, randomized, doubleblind controlled study (MRDCS) of intramedullary
decompression for complete acute (less than 24 hours
after injury) spinal cord contusion injury (IDCASCCI).
Sixty patients suffering from acute complete spinal
cord injury (20 with cervical segment 4-thoracic 1,
20 with thoracic 2-thoracic 9, and 20 with thoracic
10-lumbar vertebra 1) are collected according to the
selected conditions and randomized dividing into two
groups in above listed three segment injury area. All
patients receive conventional treatments including
reduction and fixation of spine fractures and/or spine
spondylolisthesis, bone external decompression relieves
spinal cord compression. At the same time, group A
(n = 30) undergoes intramedullary decompression and
group B (n = 30) does not undergo intramedullary
decompression. All relevant evaluated functions are
recorded before, after, and during the follow-up
period.
2.3

Subjects

Number of samples: 60 patients who meet the
inclusion criteria with acute (less than 24 hours after
injury) complete spinal cord contusion injury in three
injured areas are involved.
2.3.1 Inclusion criteria

This trial is designed and run by The China Branch
of International Association of Neurorestoratology
(IANR).
This trial got approved by the ethics committee of
participating hospitals.
2.1

Preliminary work

Participated hospitals focus on holding meetings and
training.
The evaluation criteria focus on training and discussion of clinical examination and evaluation criteria
for acute complete spinal cord contusion injury (less
than 24 hours after injury), which include neurological
physical strength score, ASIA-SCI score, IANR-SCI
function evaluation scale, and intraspinal decompression surgery operation method. The evaluation,
data collection and operative methods should be surely
kept with same or unifying standards.

(1) Age: 18 to 60 years old; fully capable; willing to
participate in the study and can participate in
the follow-up of this study.
(2) The spinal cord injury score in three injury areas
was ASIA-A grade: 20 in cervical 4-thorax 1, 20 in
thoracic vertebra 2-thoracic vertebra 9, and 20 in
thoracic 10-lumbar vertebra 1, other neurologically
stable.
(3) Non-coma patients, cooperate when checking.
2.3.2

Exclusion criteria

(1) Coma or accompanied by severe brain injury.
(2) Accepting other clinical trials.
(3) Blood glucose < 2.7 mmol/L or > 22.2 mmol/L.
Blood pressure>150/90 mmHg, does not continue
to decline after the medication.
(4) Heart, lung, liver or kidney failure, or blood
transfusion due to severe anemia. Or a disease
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(5)
(6)
(7)
(8)
(9)

that has been diagnosed (such as a mental illness),
it is difficult to complete a study for up to 1 year.
The patient or his or her guardian is unable or
unwilling to sign an informed consent form.
Completely transverse injury of the spinal cord.
Spinal cord firearm or sharp weapon injury.
Spinal cord shock.
More than 24 hours after injury or incomplete
injury.

2.3.3

Subject withdrawal criteria

(1) The subject formally withdraws their consent (in
writing).
(2) The complication that is not caused by this study,
and the comorbidity will affect the research effect.
(3) Patients were treated with unconventional drugs
(neurotrophic factors, etc.) that should be banned
in the study during the observation period; serious
adverse reactions of drugs unrelated to the study
occurred; serious physical illnesses occurred; and
failure to follow the doctor’s advice. Failure to
adhere to the completion of follow-up studies.
The terminating researchers are not included in
the final result statistics.
(4) Postoperative spinal or intracranial infection.
(5) Death of a patient unrelated to the study.
Signed Informed Consent Form: All selected patients
are signed a written informed consent form from the
study subject or their legal guardian.
2.4

Research methods

Comprehensive treatment of acute complete spinal cord
contusion injury is an essential for patients involving
in this clinical study. They will be ensured not to delay
routine treatment or affect the prognosis as far as
possible due to participation in the study, in line with
the principles of science and ethics.
2.4.1 Intervention program
(1) Selected patients: acute spinal cord contusion
injury with ASIA A in cervical vertebra 4-thoracic
vertebra 1, thoracic vertebra 2-chest 9 and thoracic
spine 10-lumbar 1.
(2) Sample size: 20 people in each injury segment
group, a total of 60 patients.
(3) Patients in each segment group were randomly
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divided into 2 sub-groups, 10 patients in each
sub-group.
(4) Routine basic treatment: spinal fractures and/or
spondylolisthesis are routinely restored, fixed, and
to remove the extramedullary bone fragments,
intervertebral discs, ligamentum flavum and
hematoma in the spinal cord injury segment for
all patients and were enrolled in the routine
neurological rehabilitation treatment of spinal
cord injury for 1 year: (a) Group 1 conventional
basic treatment + intramedullary decompression;
(b) Group 2 conventional basic treatment.
2.4.2 Operation technique of intramedullary decompression
(1) Following extramedullary decompression, the
intramedullary surgical procedures descripted
below should be under the operating microscope.
(2) Suspend the dura mater, and cut the dura mater
with the spinal cord injury segment as the center
to expose to the upper and lower normal spinal
cord. If the dura mater is damaged, it is enlarged
along the middle longitudinal line.
(3) If the spinal cord is contused, the spinal cord is
swollen with the most severe blood vessels. The
spinal cord is cut longitudinally with a sharp
blade to a length of about 0.3−0.5 cm. The nerve
stripper is used to gently scrape the hematoma
and wash the shredded necrotic spinal cord tissue
by using 0.9% sodium chloride. Since the injury
boundary is often unclear, the intramedullary
decompression should be stopped when the spinal
cord resumes pulsation; if the spinal cord has been
exposed to laceration, the injured spinal cord
tissue and hematoma can be washed directly by
using 0.9% sodium chloride.
(4) After intramedullary decompression and pulsation recovery of the spinal cord, intermittent or
continuous suture of the dura mater should be
done. If the dural defect or local spinal cord
pressure is high, artificial dura mater should
be used and enlarged to suture the dura in order
to prevent cerebrospinal fluid leakage, residual
spinal cord and surrounding tissue to form scar
adhesion, etc.
(5) The rest of the surgical procedures are routinely
processed.
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2.4.3

Observing items

Neurological physical strength score:
ASIA-SCI score;
IANR-SCI Function Assessment Scale;
Kunming Walking Classification (KLS);
MRI scan: thin scan at the lesion (2mm), DTI.
There are 5 time observation: before treatment, and
1 month, 3 months, 6 months, 1 year after treatment.
Check item:
Pre-treatment examination (before treatment):
Routine laboratory tests (blood routine, coagulation
mechanism, urine routine, liver function, renal function,
hepatitis B, anti-HIV, anti-HCV, syphilis antibody, chest
X-ray, ECG);
MRI examination;
Neurological physical strength score;
ASIA-SCI score;
IANR-SCI Function Assessment Scale;
Video of physical examination;
Photo of special signs;
1 month, 3 months, 6 months, and 12 months after
treatment:
Routine laboratory tests (blood routine, liver function,
renal function, hepatitis B, anti-HIV, anti-HCV, syphilis
antibodies);
Neurological physical strength score;
ASIA-SCI score;
IANR-SCI Function Assessment Scale;
Kunming Walking Classification (KLS);
Medical examination video;
Patient sign photo.
Follow-up plan:
Patients will be regularly followed up and evaluated
1 year after treatment. At the beginning of the study, we
will get: (1) patient’s mailing address, phone number,
email address and WeChat. (2) Contact telephones
such as home phones and mobile phones. At the
beginning of the follow-up, the patient will be notified
by phone in advance. The researchers will contact the
patient at least once a month and make adjustments
to the study plan if necessary.
2.4.4

Random method and blind method:

According to the uniform serial number and random
double-blind form for the eligible patients, two groups

of patients are to be treated in the enrolled hospitals.
The independent third-party does evaluation in pretreatment, post-treatment following-up.
Safety evaluation: All selected patients should record
adverse events after treatment, such as fever, new
neurological symptoms, etc.

3

3.1

Possible complications and treatment
strategies
Complications

They include surgical area bleeding, cerebrospinal fluid
leakage, operative injury, and rejection of implants.
3.2

Countermeasures

The operative procedures must be precise and gentle.
Gelatin sponge and cotton pad is used to stop bleeding. Stitching and repairing the dura mater should
be strict.
Postoperative complications such as cerebrospinal
fluid leakage, surgical infection should be prevented
through strictly aseptic and high quality dural repair.

4

Data analysis

The SPSS statistical software will be used for data
analysis of this subject research. One-way ANOVA
was used for the measurement data plan, and there
was a significant difference at P<0.05.

5

Attribution of this research results

This study, IDCASCCI-MRCS, was organized and
implemented by the China Branch of International
Association of Neurorestoratology (IANR), but the
results of each project belonged to the specific units
and individuals involved in the study. The size of the
contribution, that is, the number of cases in each
selected hospital, determines the order of the articles
and achievements. The postscript of the article
indicates that the China Branch of International
Association of Neurorestoratology (IANR) approves
and leads the implementation, and lists supporting
units of research fee source.
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6

Patient compensation

The patients in treatment group may get some benefits
in this trial. The patients in control group may be
no longer able to get those benefits if the results of
treatment are confirmed to be statistically better than
that of control at the end of the study. The China
Branch of IANR will have priority to give other
effective treatment if patients in the control group are
willingness to get.

7

Discussion

This study IDCASCCI-MRCS is the first multi-center
randomized double-blind clinical study for acute
(less than 24 hours after injury) spinal cord contusion
injury in the world, and hopes to obtain a clearer
conclusion.
The characteristics of this study are:
(1) Although the study of intramedullary decompression for acute spinal cord injury has been
studied for decades, it is still controversial. The
main reason is that most of the results are singlecenter studies and lacking a higher level of
evidence-based medical evidence. Therefore, this
trial is designed a multicenter randomized doubleblind and placebo-control clinical study.
(2) The SCI types are complex, including contusions,
bullet wounds, transverse injuries, ischemic
injuries, and traction injuries. This study tests
whether the spinal cord contusion injury (the
most common cases) in clinical practice can get
benefits from intramedullary decompression.
The results will have more practical guiding
significance for complete acute SCI [15−23].
(3) In this study, the patient's inclusion criteria and
exclusion criteria are clear, reducing the confusing
effects on the final outcome judgment.
(4) The third-party independent evaluation in this
study can make the results more objective
(5) The operative procedure of this study was performed under a microscope, which can avoid the
extra procedure damage and affect the results.

8

Ethics and dissemination

The clinical study (IDCASCCI-MRCS) protocol and
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consent form were approved by China Branch of
International Association of Neurorestoratology
and the ethics committee of the hospitals which
join this study. Registration No. of this study is
ChiCTR1800020458. Findings will be published in
peer-reviewed journal.
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